BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24464992)

  • 1. Interplay between pre-mRNA splicing and microRNA biogenesis within the supraspliceosome.
    Agranat-Tamir L; Shomron N; Sperling J; Sperling R
    Nucleic Acids Res; 2014 Apr; 42(7):4640-51. PubMed ID: 24464992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural studies of the endogenous spliceosome - The supraspliceosome.
    Sperling J; Sperling R
    Methods; 2017 Aug; 125():70-83. PubMed ID: 28412289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-mRNA splicing order is predetermined and maintains splicing fidelity across multi-intronic transcripts.
    Choquet K; Baxter-Koenigs AR; Dülk SL; Smalec BM; Rouskin S; Churchman LS
    Nat Struct Mol Biol; 2023 Aug; 30(8):1064-1076. PubMed ID: 37443198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing.
    Garcia-Blanco MA
    J Clin Invest; 2003 Aug; 112(4):474-80. PubMed ID: 12925685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Illuminating the role of chaperones in spliceosome biogenesis and recycling.
    Zhang S
    Nat Struct Mol Biol; 2024 May; 31(5):735-736. PubMed ID: 38664567
    [No Abstract]   [Full Text] [Related]  

  • 6. The Supraspliceosome - A Multi-Task Machine for Regulated Pre-mRNA Processing in the Cell Nucleus.
    Shefer K; Sperling J; Sperling R
    Comput Struct Biotechnol J; 2014 Sep; 11(19):113-22. PubMed ID: 25408845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supraspliceosomes at defined functional states portray the pre-assembled nature of the pre-mRNA processing machine in the cell nucleus.
    Kotzer-Nevo H; de Lima Alves F; Rappsilber J; Sperling J; Sperling R
    Int J Mol Sci; 2014 Jun; 15(7):11637-64. PubMed ID: 24983480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross talk between spliceosome and microprocessor defines the fate of pre-mRNA.
    Mattioli C; Pianigiani G; Pagani F
    Wiley Interdiscip Rev RNA; 2014; 5(5):647-58. PubMed ID: 24788135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drosha promotes splicing of a pre-microRNA-like alternative exon.
    Havens MA; Reich AA; Hastings ML
    PLoS Genet; 2014 May; 10(5):e1004312. PubMed ID: 24786770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer.
    Sun L; Wan A; Zhou Z; Chen D; Liang H; Liu C; Yan S; Niu Y; Lin Z; Zhan S; Wang S; Bu X; He W; Lu X; Xu A; Wan G
    Gut; 2021 Sep; 70(9):1698-1712. PubMed ID: 33219048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RALY may cause an aggressive biological behavior and a dismal prognosis in non-small-cell lung cancer.
    Song G; Guo G; Du T; Li X; Wang J; Yan Y; Zhao Y
    Exp Cell Res; 2020 Apr; 389(2):111884. PubMed ID: 32014444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism.
    Lee J; Yesilkanal AE; Wynne JP; Frankenberger C; Liu J; Yan J; Elbaz M; Rabe DC; Rustandy FD; Tiwari P; Grossman EA; Hart PC; Kang C; Sanderson SM; Andrade J; Nomura DK; Bonini MG; Locasale JW; Rosner MR
    Nature; 2019 Apr; 568(7751):254-258. PubMed ID: 30842661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer.
    Xu J; Liu Y; Li Y; Wang H; Stewart S; Van der Jeught K; Agarwal P; Zhang Y; Liu S; Zhao G; Wan J; Lu X; He X
    Nat Nanotechnol; 2019 Apr; 14(4):388-397. PubMed ID: 30804480
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Niu Y; Wan A; Lin Z; Lu X; Wan G
    Acta Pharm Sin B; 2018 Oct; 8(6):833-843. PubMed ID: 30505654
    [No Abstract]   [Full Text] [Related]  

  • 16. RNA modifications modulate gene expression during development.
    Frye M; Harada BT; Behm M; He C
    Science; 2018 Sep; 361(6409):1346-1349. PubMed ID: 30262497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA targeting and alternative splicing in the stress response - events hosted by membrane-less compartments.
    Kucherenko MM; Shcherbata HR
    J Cell Sci; 2018 Feb; 131(4):. PubMed ID: 29444950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for the specific and multivariant recognitions of RNA substrates by human hnRNP A2/B1.
    Wu B; Su S; Patil DP; Liu H; Gan J; Jaffrey SR; Ma J
    Nat Commun; 2018 Jan; 9(1):420. PubMed ID: 29379020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter-bound METTL3 maintains myeloid leukaemia by m
    Barbieri I; Tzelepis K; Pandolfini L; Shi J; Millán-Zambrano G; Robson SC; Aspris D; Migliori V; Bannister AJ; Han N; De Braekeleer E; Ponstingl H; Hendrick A; Vakoc CR; Vassiliou GS; Kouzarides T
    Nature; 2017 Dec; 552(7683):126-131. PubMed ID: 29186125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hnRNP RALY regulates transcription and cell proliferation by modulating the expression of specific factors including the proliferation marker E2F1.
    Cornella N; Tebaldi T; Gasperini L; Singh J; Padgett RA; Rossi A; Macchi P
    J Biol Chem; 2017 Dec; 292(48):19674-19692. PubMed ID: 28972179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.